After multiple rejections over the years, Cintas is offering a $350 million payment if the deal is rejected to sweeten the ...
London's blue-chip index has teetered on the edge of 10,000 points for the past few months, but is yet to reach the milestone ...
These 11 companies are set to raise a little over Rs 755 crore through their IPOs, including the sole mainboard maiden issue of Gujarat Kidney & Super Speciality, worth Rs 250.8 crore.